Alternate Health Club vs myRocky
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Alternate Health Club
Best for patients who want compounded GLP-1 bundled with structured workout and dietary plans, at a competitive monthly price, and who are comfortable verifying state coverage + billing terms directly with the platformStarting at $129/mo
myRocky
Best for US patients in the 42 supported states who specifically want brand-name FDA-approved GLP-1 receptor agonists without insurance involvement AND are also managing additional conditions covered by myRocky's multi-product platform (sexual health, hair loss, mental health) so the $99/mo program fee amortizes across multiple medications. NOT recommended for patients sensitive to total monthly cost — compounded providers ($99-$199/mo) and direct manufacturer programs (NovoCare, LillyDirect) offer better economics.Starting at $1409/mo
Side-by-Side Comparison
| Feature | Alternate Health Club | myRocky |
|---|---|---|
| Overall Score | ✓7.3/10 | 6.1/10 |
| Starting Price | ✓$129/mo | $1409/mo |
| Editorial Rating | ✓3.7 ★ /5 | 3.1 ★ /5 |
| Features | 6 features | ✓8 features |
| States Available | 0 | 0 |
| Compounded | ✓ Yes | — |
| Brand Name | — | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Alternate Health Club
Pros
- ✓$129/month compounded semaglutide is in the cheapest decile of the US compounded telehealth market
- ✓$169/month compounded tirzepatide is competitive with established compounded-tirz platforms
- ✓Complimentary workout & dietary plans included alongside medication — most peer platforms don't bundle this
- ✓LegitScript Verified seal displayed in the footer
- ✓U.S.-licensed clinicians explicitly mentioned
Cons
- ✗Parent company / legal entity name NOT publicly disclosed — material YMYL transparency gap
- ✗State of incorporation NOT disclosed
- ✗Per-state availability NOT enumerated — verify your state ships before committing
- ✗Pharmacy partners NOT publicly named — material YMYL transparency gap
- ✗Lab work NOT clearly disclosed as included
- ✗Billing cadence (monthly vs quarterly vs annual) NOT clearly disclosed on home page
- ✗First-month discount or trial offer NOT disclosed
myRocky
Pros
- ✓Brand-name FDA-approved GLP-1 receptor agonists (Ozempic, Mounjaro, Wegovy) on a single platform — no compounded-product YMYL risk
- ✓LegitScript Approved (#44796030)
- ✓42-state US coverage with 8-state Phase 2 expansion roadmap published
- ✓Multi-product platform appeals to patients managing multiple conditions (GLP-1 + sexual health + hair loss + mental health) on one subscription
Cons
- ✗Stacked-fee structure is expensive: $99 consultation + $99/mo program fee + $1,409/mo medication = ~$1,508/mo first month, ~$1,508/mo ongoing — well above typical compounded providers ($99-$199/mo all-in) and above LillyDirect Self Pay Journey Program ($449-$699/mo Zepbound vials)
- ✗Canadian incorporation (Rocky Health Inc., Mississauga, ON L4W 5M8) with US-state prescriber operationalization opaque — patients should verify their state's prescriber holds an active US license before enrolling
- ✗Listed pharmacy (Rocky Pharmacy #308582, Mississauga ON) is a Canadian community pharmacy — US-fulfillment supply chain not transparent on public-facing pages
- ✗Multi-product platform may indicate prescriber bandwidth is split across many conditions (less GLP-1-specific expertise vs single-product specialists)
- ✗Brand-only (no compounded option) limits cost-sensitive patient access
- ✗$1,409/mo Ozempic pricing is near-retail; insured patients should pursue PA through traditional pharmacy for better economics — uninsured patients should compare NovoCare ($349/mo Wegovy pen ongoing) or LillyDirect Self Pay ($449-$699/mo Zepbound vials)
Our Verdict
Alternate Health Club edges out myRocky with a higher overall score of 7.3/10 and is particularly strong for patients who want compounded GLP-1 bundled with structured workout and dietary plans, at a competitive monthly price, and who are comfortable verifying state coverage + billing terms directly with the platform. myRocky remains a solid alternative, especially if you're looking for US patients in the 42 supported states who specifically want brand-name FDA-approved GLP-1 receptor agonists without insurance involvement AND are also managing additional conditions covered by myRocky's multi-product platform (sexual health, hair loss, mental health) so the $99/mo program fee amortizes across multiple medications. NOT recommended for patients sensitive to total monthly cost — compounded providers ($99-$199/mo) and direct manufacturer programs (NovoCare, LillyDirect) offer better economics..
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.